Clinical Scientist Consultant

Walker Cole International is currently partnered with a client searching for a Freelance Clinical Scientist – Neuroscience in the United Kingdom for an initial 6-month contract commencing in 2026 to support a First-in-Human (FIH) Phase I clinical study.

Key Responsibilities:

• Provide scientific leadership for a First-in-Human Phase I neuroscience clinical trial.
• Support the design, development, and execution of clinical study protocols, amendments, and associated documents.
• Contribute to the preparation of Investigator’s Brochures (IB), Clinical Study Reports (CSRs), and regulatory submissions.
• Collaborate with Clinical Operations to ensure high-quality study delivery in line with timelines and objectives.
• Monitor and interpret clinical data, ensuring scientific integrity, patient safety, and data accuracy.
• Support dose-escalation decisions, safety reviews, and data interpretation alongside medical and safety teams.
• Act as a key liaison between cross-functional teams, including Regulatory Affairs, Biostatistics, Pharmacovigilance, and Medical Affairs.
• Contribute to safety monitoring activities, including review of adverse events and Data Monitoring Committee materials.
• Ensure compliance with ICH-GCP, UK regulatory requirements, and company SOPs.
• Support publications, abstracts, and presentations arising from clinical studies.

Required Qualifications:

• Advanced degree (PhD, PharmD, MD, or MSc) in Neuroscience, Pharmacology, Life Sciences, or a related discipline.
• Minimum of 3–5 years of experience in clinical research within a biotech, pharmaceutical, or CRO environment.
• Proven experience supporting early-phase clinical trials, particularly First-in-Human or Phase I studies.
• Strong understanding of clinical trial methodology, data analysis, and interpretation.
• Knowledge of ICH-GCP and UK regulatory requirements, including MHRA guidelines.
• Experience in protocol development and clinical study documentation.
• Excellent analytical, scientific writing, and communication skills.
• Proficiency in Microsoft Office Suite.

Preferred Qualifications:

• Therapeutic expertise in neuroscience, such as neurodegenerative diseases, psychiatry, or CNS disorders.
• Experience with dose-escalation designs, including SAD/MAD studies.
• Familiarity with biomarkers, neuroimaging, and exploratory endpoints in early-phase trials.
• Experience working in a small or mid-sized biotech environment.
• Prior involvement in regulatory interactions with the MHRA.
• Publication record in peer-reviewed scientific journals.

Contract Details:

• Start Date: April 2026
• Work Schedule: 3–5 days per week
• Rate: £90–£120 per hour (dependent on experience level)
• Duration: 6 months (with likely extension)
• Location: United Kingdom – Remote (with occasional on-site meetings as required)

Clinical Scientist | Neuroscience | CNS | First-in-Human | FIH | Phase I | Early Phase | Clinical Development | Contract | Contractor | Biotech | Biopharma | MHRA | Remote UK